"Austin Regional Clinic administrative building is located at 6210 E. US Highway 290, Austin, TX 78723. We are a multispecialty group offering you accessible, reliable, convenient healthcare. Focusing on primary care - family practice, pediatrics, internal medicine, general surgery, dermatology, orthopedics and more."

During the past decade, Austin Regional Clinic conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 22 clinical trials were completed, i.e. on average, 71% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 10 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Austin Regional Clinic" #1 sponsor was "Amgen" with 6 trials, followed by "Janssen Research & Development, LLC" with 6 trials sponsored, "University of Texas at Austin" with 5 trials sponsored, "Exact Sciences Corporation" with 4 trials sponsored and "Pfizer" with 4 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Austin Regional Clinic" #1 collaborator was "Dyax Corp." with 1 trials as a collaborator and "Stanford University" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Austin Regional Clinic" are "Rheumatoid Arthritis" (7 trials), "Psoriatic Arthritis" (5 trials), "Arthritis, Psoriatic" (4 trials), "Colorectal Cancer" (3 trials) and "Systemic Lupus Erythematosus" (3 trials). Many other conditions were trialed in "Austin Regional Clinic" in a lesser frequency.

Most popular intervention types in "Austin Regional Clinic" are "Drug" (24 trials), "Other" (10 trials), "Biological" (6 trials), "Procedure" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Guselkumab" (4 trials), "Apremilast 20mg" (2 trials), "Apremilast 30 mg" (2 trials) and "Apremilast 30mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Austin Regional Clinic" are 38 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Austin Regional Clinic". 1 are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Austin Regional Clinic, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Austin Regional Clinic, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".